Rastreamento ajustado por raça e etnia e ensaio genômico na doença ERBB2-positivo após QT neoadjuvante

Notas do episódio

Referências: Chen T, Kharazmi E, Fallah M. Race and Ethnicity-Adjusted Age Recommendation for Initiating Breast Cancer Screening. JAMA Netw Open. 2023;6(4):e238893. doi:10.1001/jamanetworkopen.2023.8893 https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2803948 Bueno-Muiño C, Echavarría I, López-Tarruella S, et al. Assessment of a Genomic Assay in Patients With ERBB2-Positive Breast Cancer Following Neoadjuvant Trastuzumab-Based Chemotherapy With or Without Pertuzumab. JAMA Oncol. Published online April 27, 2023. doi:10.1001/jamaoncol.2023.0187 https://jamanetwork.com/journals/jamaoncology/article-abstract/2804134 --